Page 150 - Read Online

Environ Res Public Health 2013;10:3834-42. Elevated interleukin-6 during ethanol consumption acts as a potential
3. Sultani M, Stringer AM, Bowen JM, Gibson RJ. Anti-inflammatory endogenous protective cytokine against ethanol-induced apoptosis
cytokines: important immunoregulatory factors contributing to in the liver: involvement of induction of Bcl-2 and Bcl-xL proteins.
chemotherapy induced gastrointestinal mucositis. Chemother Res Oncogene 2002;21:32-43.
Pract 2012;2012:490804. 27. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol
4. Allavena P, Germano G. Marchesi F, Mantovani, A. Chemokines in 2005;2:92-100.
cancer related inflammation. Exp Cell Res 2011;317:664-73. 28. Kasztelan-Szczerbińska B, Surdacka A, Celiński K, Roliński J,
5. Matei I, Matei L. Cytokine patterns and pathogenicity in autoimmune Zwolak A, Miącz S, and Szczerbiński M. Prognostic significance
disease. Rom J Intern Med 2002;40:27-41. of the systemic inflammatory and immune balance in alcoholic
6. Pasha HF, Radwan MI, Hagrass HA, Tantawy EA, Emara MH. liver disease with a focus on gender-related differences. PLoS One
Cytokines genes polymorphisms in chronic hepatitis C: impact 2015;10:e0128347.
on susceptibility to infection and response to therapy. Cytokine 29. Zhang X, Tachibana S, Wang H, Hisada M, Williams GM, Gao B, Sun
2013;61:478-84. Z. Interleukin-6 is an important mediator for mitochondrial DNA repair
7. Cohen MC, Cohen S. Cytokine function: a study in biologic diversity. after alcoholic liver injury in mice. Hepatology 2010;52:2137-47.
Am J Clin Pathol 1996;105:589-98. 30. Lemmers A, Moreno C, Gustot T, Maréchal R, Degré D, Demetter
8. Ikram N, Hassan K, Tufail S. Cytokines. Int J Pathol 2004;2:47-58. P, de Nadai P, Geerts A, Quertinmont E, Vercruysse V, Le Moine O,
9. SekIyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory Devière J. The interleukin-17 pathway is involved in human alcoholic
cytokines (IL-ll3, TNF-a, and IL-6) and IL-1 receptor antagonist liver disease. Hepatology 2009;49:646-57.
(IL-lRa) in fulminant hepatic failure and acute hepatitis. Clin Exp 31. Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau
Immunol 1994;98:71-7. M, Min SY, Kurt-Jones EA, Szabo G. IL-1 receptor antagonist
10. Oppenheim JJ. Cytokines: past, present, and future. Int J Hematol ameliorates inflammasome-dependent alcoholic steatohepatitis in
2001;74:3-8. mice. J Clin Invest 2012;122:3476-89.
11. Slifka MK, Whitton JL. Clinical implication of dysregulated cytokine 32. Abd El-Kader SM, El-Den Ashmawy EM. Non-alcoholic fatty liver
production. J Mol Med (Berl) 2000;78:74-80. disease: the diagnosis and management. World J Hepatol 2015;7:846-
12. Angkasekwinai P, Dong C. T 17 Cytokines: Characteristics, Regulation, 58.
H
and Biological Function. In: Jiang S, editor. T 17 Cells in Health and 33. Lalor PF, Faint J, Aarbodem Y, Hubscher SG, Adams DH. The role
H
Disease. Berlin: Springer Science+Business Media LLC; 2011. of cytokines and chemokines in the development of steatohepatitis.
13. Racanelli V, Rehermann B. The liver as an immunological organ. Semin Liver Dis 2007;27:173-93.
Hepatology 2006;43:S54-62. 34. Brenner DA, O’Hara M, Angel P, Chojkier M, Karin M. Prolonged
14. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor activation of jun and collagenase genes by tumor necrosis factor-
antagonist: role in biology. Annu Rev Immunol 1998;16:27-55. alpha. Nature 1989;337:661-3.
15. Symons JA, Young PR, Duff GW. Soluble type II interleukin I (IL- 35. Olteanu S, Kandel-Kfir M, Shaish A, Almog T, Shemesh S, Barshack I,
1) receptor binds and blocks processing of IL-1β precursor and Apte RN, Harats D, Kamari Y. Lack of interleukin-1α in Kupffer cells
loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci U S A attenuates liver inflammation and expression of inflammatory cytokines
1995;92:1714-8. in hypercholesterolaemic mice. Dig Liver Dis 2014;46:433-9.
16. Ceni E, Mello T, Galli A. Pathogenesis of alcoholic liver disease: Role 36. Ikejima K, Okumura K, Kon K, Takei Y, Sato N. Role of adipocytokines
of oxidative metabolism. World J Gastroenterol 2014;20:17756-72. in hepatic fibrogenesis. J Gastroenterol Hepatol 2007;22 Suppl
17. McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent advances 1:S87-92.
in alcoholic liver disease: IV- Dysregulated cytokine metabolism 37. Rajala MW, Scherer PE. Minireview: The adipocyte-at the cross
in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol roads of energy homeostasis, inflammation, and atherosclerosis.
2004;287:G497-502. Endocrinology 2003;144:3765-73.
18. Kitazawa T, Nakatani Y, Fujimoto M, Tamura N, Uemura M, Fukui 38. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A,
H. The production of tumor necrosis factor-α by macrophages in rats Richelsen B. Regulation of adiponectin by adipose tissue-derived
with acute alcohol loading. Alcohol Clin Exp Res 2003;27:S72-5. cytokines: in vivo and in vitro investigations in humans. Am J Physiol
19. Tsujimoto T, Kuriyama S, Yamazaki M, Nakatani Y, Okuda H, Yoshiji Endocrinol Metab 2003;285:E527-33.
H, Fukui H. Augmented hepatocellular carcinoma progression and 39. Hukshorn CJ, Lindeman JH, Toet KH, Saris WH, Eilers PH, Westerterp-
depressed Kupffer cell activity in rat cirrhotic livers. Int J Oncol Plantenga MS, Kooistra T. Leptin and the proinflammatory
2001;18:41-7. state associated with human obesity. J Clin Endocrinol Metab
20. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense 2004;89:1773-8.
and liver disease. Liver Int 2006;26:1175-86. 40. You T, Berman DM, Rayan S, Nicklas BJ. Effect of hypocaloric diet
21. Diehl AM. Recent events in alcoholic liver disease: V. Effects of and exercise training on inflammation and adipocyte lipolysis in obese
ethanol on liver regeneration. Am J Physiol Gastrointest Liver post-menopausal women. J Clin Endocrinol Metab 2004;89:1739-46.
Physiol 2005;288:G1-6. 41. Pravo PE, Morse S, Borne DM, Aguilar EA, Reisin E. Leptin and
22. Aldred ND, Nagy LE. Ethanol dissociates hormone stimulated cAMP hypertension. Vasc Health Risk Manag 2006;2:163-9.
production from inhibition of TNF-α production in rat Kupffer cells. 42. Popper H. Cholestasis: the future of a past and present riddle.
Am J Physiol 1999;276:G98-106. Hepatology 1981;1:187-91.
23. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ. 43. Keith G, Tolman MD, Rej R. Liver function. In: Burtis CA, Ashwood
Increased plasma interleukin-6 concentrations in alcoholic hepatitis. ER, Tietz NW, editors. Tietz Textobook of Clinical Chemistry,
J Lab Clin Med 1992;119:547-52. Volume 3, Chapter 33. Philadelphia, PA: W.B. Saunders; 1999.
24. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. 44. Spirlì C, Fabris L, Duner E, Fiorotto R, Ballardini G, Roskams T,
Pentoxifylline improves short-term survival in severe acute alcoholic Larusso NF, Sonzogni A, Okolicsanyi L, Strazzabosco M. Cytokine-
hepatitis: a double-blind, placebo-controlled trial. Gastroenterology stimulated nitric oxide production inhibits adenyl cyclase and
2000;119:1637-48. cAMP-dependent secretion in cholangiocytes. Gastroenterology
25. Tilg H, Jalan R, Kaser A, Davies NA, Offner FA, Hodges SJ, 2003;124:737-53.
Ludwiczek O, Shawcross D, Zoller H, Alisa A, Mookerjee RP, 45. Ahmed HH, Mannaa F. Curcumin as an effective agent against
Graziadei I, Datz C, Trauner M, Schuppan D, Obrist P, Vogel W, ethinylestradiol-induced hepatocellular cholestaris. Egypt J Med Lab
Williams R. Anti-tumor necrosis factor alpha monoclonal antibody Sci 2004;13:1-16.
therapy in severe alcoholic hepatitis. J Hepatol 2003;38:419-25. 46. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters
26. Hong F, Kim WH, Tian Z, Jaruga B, Ishac E, Shen X, Gao B. JJ. Mechanism of hepatotoxicity. Toxicol Sci 2002;65:166-76.

Hepatoma Research | Volume 2 | June 1, 2016 141